# Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

> **NCT05658575** · PHASE2,PHASE3 · RECRUITING · sponsor: **Olatec Therapeutics LLC** · enrollment: 300 (estimated)

## Conditions studied

- Acute Gout Flare
- Gout Attack
- Gout Flare
- Gouty Arthritis
- Gout
- Arthritis
- Joint Pain

## Interventions

- **DRUG:** Dapansutrile
- **OTHER:** Placebo Tablet

## Key facts

- **NCT ID:** NCT05658575
- **Lead sponsor:** Olatec Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05658575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05658575, "Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT05658575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*